[Effects of small interference RNA targeting connective tissue growth factor on hypoxia-induced collagen synthesis in

You-juan Wang1, Yan Huang, Hui Tang

  • 1Laboratory of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

Small interference RNA (siRNA) targeting connective tissue growth factor (CTGF) effectively reduced collagen synthesis in human lung fibroblasts under hypoxic conditions. This suggests siRNA as a potential therapeutic strategy for fibrotic lung diseases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Hypoxia, a condition of low oxygen, can induce excessive collagen synthesis in lung fibroblasts.
  • Connective tissue growth factor (CTGF) plays a significant role in fibrotic processes, including collagen deposition.

Purpose of the Study:

  • To evaluate the efficacy of small interference RNA (siRNA) targeting CTGF in mitigating hypoxia-induced collagen synthesis in human lung fibroblasts.
  • To investigate the molecular mechanisms underlying CTGF's role in fibrotic responses to hypoxia.

Main Methods:

  • Stable transfection of MRC-5 cells with CTGF-siRNA expression plasmid.
  • Culture of transfected cells under hypoxic conditions (1% O2) for varying durations (1-12 hours).
  • Assessment of CTGF and collagen type I expression using real-time quantitative PCR and Western blot analysis.

Main Results:

  • Hypoxia significantly upregulated CTGF mRNA expression in control cells within 1 hour, sustained for up to 6 hours.
  • CTGF-siRNA transfection markedly reduced hypoxia-induced CTGF mRNA and protein expression in MRC-5 cells.
  • Collagen type I deposition was significantly decreased in CTGF-siRNA treated cells compared to controls.

Conclusions:

  • siRNA targeting the CTGF gene effectively inhibits collagen deposition induced by hypoxia in human lung fibroblasts.
  • CTGF is a key mediator of collagen synthesis under hypoxic conditions, making it a potential therapeutic target for lung fibrosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...